Puma Biotechnology Inc Share Price Nyse
Equities
US74587V1070
Biotechnology & Medical Research
Sales 2024 * | 219M 17.44B | Sales 2025 * | 225M 17.93B | Capitalization | 248M 19.73B |
---|---|---|---|---|---|
Net income 2024 * | 10M 797M | Net income 2025 * | 15M 1.19B | EV / Sales 2024 * | 1.13 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.1 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
21.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.6% |
Latest transcript on Puma Biotechnology Inc
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 14/09/10 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 04/11/18 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 28/02/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 22/02/18 |
Jay Moyes
BRD | Director/Board Member | 70 | 26/04/12 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 14/09/10 |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |